Akebia Therapeutics (AKBA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | AKBA | KALV | LRMR | ||
| Company | Akebia Therapeutics | Kalvista Pharmaceuticals Inc | Larimar Therapeutics Inc | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 1.8400 | 9.39 | 6.16 | ||
| High | 1.8995 | 10.22 | 6.34 | ||
| Low | 1.8050 | 9.30 | 6.04 | ||
| Last | 1.8800 | 10.15 | 6.16 | ||
| Change | +0.0600 | +0.82 | +0.03 | ||
| % Change | +3.30% | +8.85% | +0.49% | ||
| Volume | 2,011,100 | 405,000 | 402,000 | ||
| 20-Day Average Volume | 2,432,105 | 432,490 | 759,645 | ||
| Previous Close | 1.8200 | 9.32 | 6.13 | ||
| Industry | Medical - Drugs | Medical - Drugs | Medical - Drugs | ||
| Has Options | Yes | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 1.8262 | 10.56 | 7.64 | ||
| 20-Day Raw Stochastic | 67.82% | 34.15% | 12.57% | ||
| 20-Day Relative Strength | 61.39% | 45.11% | 40.34% | ||
| Weighted Alpha | +40.74 | -3.65 | -13.84 | ||
| Today's Opinion | 100% Buy | 100% Sell | 88% Sell | ||
| Previous Opinion | 100% Buy | 100% Sell | 88% Sell | ||
| Last Month's Opinion | 56% Buy | 24% Sell | Hold | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | +5.03% since 11/15/24 | +6.95% since 11/15/24 | -7.92% since 11/15/24 | ||
| Low | 1.7500 on 11/21/24 | 8.75 on 11/21/24 | 5.68 on 11/21/24 | ||
| High | 1.8995 on 11/22/24 | 10.22 on 11/22/24 | 6.62 on 11/18/24 | ||
| 1-Month | |||||
| %Chg | +14.63% since 10/22/24 | -17.81% since 10/22/24 | -18.19% since 10/22/24 | ||
| Low | 1.5400 on 10/23/24 | 8.75 on 11/21/24 | 5.68 on 11/21/24 | ||
| High | 2.0200 on 11/11/24 | 12.85 on 11/04/24 | 9.50 on 11/11/24 | ||
| 3-Month | |||||
| %Chg | +27.89% since 08/22/24 | -18.28% since 08/22/24 | -20.10% since 08/22/24 | ||
| Low | 1.2400 on 10/01/24 | 8.75 on 11/21/24 | 5.68 on 11/21/24 | ||
| High | 2.0200 on 11/11/24 | 13.52 on 09/03/24 | 9.50 on 11/11/24 | ||
| 6-Month | |||||
| %Chg | +70.91% since 05/22/24 | -13.17% since 05/22/24 | -22.03% since 05/22/24 | ||
| Low | 0.8000 on 06/26/24 | 8.75 on 11/21/24 | 5.68 on 11/21/24 | ||
| High | 2.0200 on 11/11/24 | 15.50 on 07/24/24 | 11.20 on 07/16/24 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 397,089 | 402,980 | 391,137 | ||
| Shares Outstanding, K | 218,181 | 43,215 | 63,807 | ||
| Annual Sales | 194,620,000 | 0 | 0 | ||
| Annual Net Income | -51,930,000 | -126,640,000 | -36,950,000 | ||
| Last Quarter Sales | 37,430,000 | 0 | 0 | ||
| Last Quarter Net Income | -20,040,000 | -40,440,000 | -15,500,000 | ||
| 60-Month Beta | 0.74 | 0.92 | 0.95 | ||
| Per-Share Information | |||||
| Most Recent Earnings | -0.10 on 11/07/24 | -0.87 on 09/05/24 | -0.24 on 10/30/24 | ||
| Latest Earnings Date | 11/07/24 | 12/05/24 | 11/12/24 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 0.00 | 0.00 | ||